Patients with potentially fatal COVID-19 were discovered to exhibit rare variations in 13 loci that contribute to loss of function and, thus, defective IFN pathway, according to a study conducted by Zhang et al. [57]. This evidence concerns the gene IFNA1 and COVID-19.